Wearable phototherapy device with organic light-emitting diode

Abstract

This invention provides a wearable organic light-emitting diode (OLED) phototherapy device, the structure of which includes: a carrier comprising an accommodating space; a flexible OLED module disposed within the accommodating space, the flexible OLED module further comprising: a transparent substrate; an anode; a hole injection layer; a hole transport layer; an organic light-emitting layer, the organic light-emitting layer further comprising: a first red light guest layer; a second red light guest layer; an electron transport layer; and a cathode; a power supply module electrically connected to the OLED module; wherein the light emission wavelength range of the organic light-emitting layer is 550 to 800 nanometers and is used to increase blood oxygen concentration.

Claims

1. A wearable organic light-emitting diode (OLED) phototherapy device, comprising: a carrier including a receiving space; a flexible OLED module disposed within the receiving space, the flexible OLED module further comprising: a transparent substrate; an anode disposed on the transparent substrate; a hole injection layer disposed on the anode; a hole transport layer disposed on the hole injection layer; an organic light-emitting layer disposed on the hole transport layer, the organic light-emitting layer further comprising: a first red light guest layer; and a second red light guest layer disposed on the first red light guest layer; an electron transport layer disposed on the organic light-emitting layer; and a cathode disposed on the electron transport layer; and a power supply module disposed on one side of the carrier and electrically connected to the OLED module; wherein... One of the organic light-emitting layers emits light in the range of 550 to 800 nanometers and is used to increase the blood oxygen concentration of a user. The material of the first red light guest layer is selected from bis(1-phenylisoquinoline)(acetoacetone)iridium(III), platinum octaethylporphyrin, iridium(III)[1,4-bis(phenyl)phthalazine], tris[1-phenylisoquinoline-C2,N]iridium(III), bis(2-(9-phenylcarbazole-2-yl)benzothiazole]iridium(III)pyridinecarboxylate, bis(phenylisoquinoline / 2,2,6,6-tetramethylheptane-3,5-diiodate)iridium(IIl), and one The material of the second red guest layer is one or a combination of the group consisting of (E)-2-(2-tert-butyl-6-(2-(2,6,6-trimethyl-2,4,5,6-tetrahydro-1H-pyrrolo[3,2,1-ij]quinoline-8-yI)vinyl))-4H-pyran-4-propylene)malonium, platinum(I)octaethylmorphine and 2-[4-(diphenylamino)phenyl]-10,10-sulfur dioxide-9H-thioxanth-9-one, and the material of the second red guest layer is bis[1-(9,9-dimethyl-9H-fluorene-2-yl)-isoquinoline](acetylacetone)iridium(III).

2. The wearable organic light-emitting diode phototherapy device as claimed in claim 1, further comprising: a connector disposed on one side of the carrier, the connector being used to connect a plurality of carriers.

3. The wearable organic light-emitting diode phototherapy device as described in claim 1, wherein the anode material is selected from one or a combination of the group consisting of indium tin oxide, indium zinc oxide, aluminum-doped zinc oxide, silver, silver nanowire, gold nanowire, copper nanowire, graphene, conductive polymer, aluminum, and nickel.

4. The wearable organic light-emitting diode phototherapy device as claimed in claim 1, wherein the material of the hole injection layer is bispyrazine (2,3-f: 2',3'-h)quinoxaline-2,3,6,7,10,11-hexacyano, 4,4'-cyclohexylbis[N,N-di(4-methylphenyl)aniline] or a combination thereof.

5. The wearable organic light-emitting diode phototherapy device as claimed in claim 1, wherein the cathode material is selected from one or a combination of the group consisting of lithium fluoride, cesium fluoride, lithium 8-hydroxyquinoline, potassium, magnesium, aluminum and calcium.

6. The wearable organic light-emitting diode phototherapy device as claimed in claim 1, wherein the hole transport layer and the electron transport layer form an excited-state complex, the material of the hole transport layer is a first excited-state complex selected from tris(4-carbazole-9-ylphenyl)amine, 4,4',4"-tris(N-3-methylphenyl-N-phenylamino)triphenylamine, and N,N'-diphenyl-N,N'-bis(phenyl-N-phenyl)amine. One of the groups consisting of (1,1'-biphenyl)-4,4'-diamine, 4,4'-(cyclohexane-1,1-diyl)bis(N,N-di-p-tolylaniline), 4-[2-(9,9'-dimethylfluorene)]-triphenylamine, and 2-(3'-(dibenzo[b,d]thiophene-4-yl)-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine. The electron transport layer material is a second excited-state complex, selected from bis(naphthyl-1-yl)-N,N'-diphenylbenzidine, 3,5,3',5'-tetra(m-pyridin-3-yl)phenyl[1,1']biphenyl, 4,7-diphenyl-1,10-phenanthroline, 4,6-bis(3,5-bis(pyridin-3-yl)phenyl)-2-methylpyrimidine, and 1,3,5-tris[ One of the groups consisting of (3-pyridyl)-benzene-3-yl]benzene, anthracene-9,10-diylbis(diphenylphosphine oxide), (1,3,5-triazine-2,4,6-triyl)tri-(benzene-3,1-diyl))tri(diphenylphosphine oxide) and 3',3''',3'''''-(1,3,5-triazine-2,4,6-triyl)tri(([1,10-biphenyl]-3-nitrile).

Images